Notfälle
Blutspende
Karriere
Presse
Forschung
Lehre
Patienten
Zuweiser

Meissner M, Whiteside T, Kaufmann R, Seliger B. CIITA versus IFN-g induced MHC class II expression in head and neck cancer cells. Arch Dermatol Res. 2009; 301:198-93.

 

Horsch M, Recktenwald CV, Schaedler S, Hrabé de Angelis M, Seliger B, Beckers J. Overexpressed vs mutated Kras in murine fibroblasts: a molecular phenotyping study. Br J Cancer. 2009;100:656-62.

 

Helgadottir H, Andersson E, Villabona L, Kanter L, van der Zanden H, Haasnoot GW, Seliger B, Bergfeldt K, Hansson J, Ragnarsson-Olding B, Kiessling R, Masucci GV. The common Scandinavian Human Leucocyte Antigen (HLA) ancestral haplotype 62.1 is a negative prognostic factor in patients with advanced malignant melanoma. Cancer Immunol Immunother. 2009; 58(10):1599-608.

 

Seliger B, Dressler SP, Wang E, Kellner R, Recktenwald CV, Lottspeich F, Marincola FM, Baumgärtner M, Atkins D, Lichtenfels R. Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma. Proteomics. 2009; 9:1567-81.

 

Kiessling A, Hogrefe C, Erb S, Bobach C, Fuessel S, Wessjohann L, Seliger B. Expression, regulation and function of the ISGylation system in prostate cancer. Oncogene. 2009; 28:2606-20.

 

Lichtenfels R, Dressler S, Zobawa M, Recktenwald CV, Ackermann A, Atkins D, Kersten M, Hesse A, Puttkammer M, Lottspeich F, Seliger BSystematic comparative protein expression profiling of clear cell renal cell carcinoma: A pilot study based on the separation of tissue specimen by two-dimensional electrophoresis. Mol Cell Proteomics. 2009; 8:2827-42.

 

Seliger B, Handke D, Schabel, E, Bukur J, Kellert C, Lichtenfels R, Dammann R. Epigenetic control of the ubiquitin carboxyl terminale hydrolase 1 in renal cell carcinoma. J Transl Med. 2009; 7:90.